Morphosys Ag ADR (MOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MOR | AMGN | GILD | BIIB | CELG |
| Company | Morphosys Ag ADR | Amgen Inc | Gilead Sciences Inc | Biogen Inc | Celgene Corp |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 18.00 | 265.64 | 67.01 | 191.75 | 108.01 |
| High | 18.08 | 265.92 | 67.02 | 192.56 | 108.59 |
| Low | 17.91 | 262.58 | 65.90 | 189.52 | 107.27 |
| Last | 18.05 | 262.75 | 66.16 | 190.52 | 108.24 |
| Change | +0.01 | -1.32 | -0.77 | -1.64 | +0.11 |
| % Change | +0.06% | -0.50% | -1.15% | -0.85% | +0.10% |
| Volume | 592,800 | 2,082,700 | 6,441,700 | 1,512,000 | 191,230,496 |
| 20-Day Average Volume | 418,035 | 2,201,900 | 6,214,885 | 1,111,075 | 16,188,930 |
| Previous Close | 18.04 | 264.07 | 66.93 | 192.16 | 108.13 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | No |
| Technicals | |||||
| 20-Day Moving Average | 18.09 | 272.96 | 70.21 | 206.35 | 108.17 |
| 20-Day Raw Stochastic | 51.43% | 0.65% | 3.10% | 3.10% | 63.25% |
| 20-Day Relative Strength | 64.86% | 36.64% | 27.91% | 26.94% | 64.69% |
| Weighted Alpha | +78.58 | +4.25 | -25.27 | -38.74 | +46.30 |
| Today's Opinion | 88% Buy | 56% Sell | 100% Sell | 100% Sell | 100% Buy |
| Previous Opinion | 88% Buy | 56% Sell | 100% Sell | 100% Sell | 100% Buy |
| Last Month's Opinion | 100% Buy | 8% Sell | 88% Sell | 100% Sell | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 04/11/24 | -2.69% since 04/11/24 | -3.63% since 04/11/24 | -6.46% since 04/11/24 | -1.97% since 11/13/19 |
| Low | 17.91 on 04/16/24 | 262.58 on 04/18/24 | 65.90 on 04/18/24 | 189.52 on 04/18/24 | 107.27 on 11/20/19 |
| High | 18.09 on 04/15/24 | 270.93 on 04/15/24 | 68.62 on 04/12/24 | 205.24 on 04/12/24 | 110.53 on 11/14/19 |
| 1-Month | |||||
| %Chg | -0.28% since 03/18/24 | -3.01% since 03/18/24 | -9.69% since 03/18/24 | -13.16% since 03/18/24 | +5.14% since 10/18/19 |
| Low | 17.87 on 04/03/24 | 262.58 on 04/18/24 | 65.90 on 04/18/24 | 189.52 on 04/18/24 | 102.40 on 10/21/19 |
| High | 18.22 on 03/25/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 221.74 on 03/21/24 | 110.70 on 11/13/19 |
| 3-Month | |||||
| %Chg | +76.27% since 01/18/24 | -13.71% since 01/18/24 | -23.43% since 01/18/24 | -22.86% since 01/18/24 | +13.63% since 08/20/19 |
| Low | 8.88 on 01/23/24 | 262.58 on 04/18/24 | 65.90 on 04/18/24 | 189.52 on 04/18/24 | 93.41 on 08/23/19 |
| High | 18.31 on 03/12/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 252.17 on 01/22/24 | 110.70 on 11/13/19 |
| 6-Month | |||||
| %Chg | +166.22% since 10/18/23 | -7.35% since 10/18/23 | -16.96% since 10/18/23 | -27.70% since 10/18/23 | +14.14% since 05/20/19 |
| Low | 4.18 on 11/22/23 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 189.52 on 04/18/24 | 89.08 on 07/23/19 |
| High | 18.31 on 03/12/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 268.30 on 01/03/24 | 110.70 on 11/13/19 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,717,203 | 141,520,144 | 83,333,008 | 27,932,570 | 77,035,920 |
| Shares Outstanding, K | 150,621 | 535,919 | 1,245,077 | 145,361 | 711,714 |
| Annual Sales | 257,890,000 | 28,190,000,000 | 27,116,000,000 | 9,835,600,000 | 15,281,000,000 |
| Annual Net Income | -205,350,000 | 6,717,000,000 | 5,665,000,000 | 1,161,100,000 | 4,046,000,000 |
| Last Quarter Sales | 63,610,000 | 8,196,000,000 | 7,114,000,000 | 2,386,300,000 | 4,520,000,000 |
| Last Quarter Net Income | 53,170,000 | 767,000,000 | 1,429,000,000 | 249,700,000 | 1,691,000,000 |
| 60-Month Beta | 1.17 | 0.58 | 0.19 | -0.02 | 1.41 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.33 on 03/13/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 2.95 on 02/13/24 | 2.99 on 10/31/19 |
| Latest Earnings Date | 05/01/24 | 05/02/24 | 04/25/24 | 04/24/24 | 10/31/19 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.24 | 10.02 | 13.25 | 10.99 |